Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
48.43 USD | -2.89% | +0.46% | -41.99% |
04/06 | B. Riley Cuts Price Target on Cytokinetics to $92 From $122, Maintains Buy Rating | MT |
03/06 | Cytokinetics Insider Sold Shares Worth $635,978, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.99% | 5.72B | |
+16.73% | 121B | |
+13.04% | 107B | |
-5.80% | 24.82B | |
+1.69% | 22.48B | |
-10.09% | 18.32B | |
-40.52% | 16.33B | |
-14.00% | 15.31B | |
+1.18% | 14.08B | |
+24.18% | 11.74B |
- Stock Market
- Equities
- CYTK Stock
- News Cytokinetics, Incorporated
- Cytokinetics Reports Positive Follow-On Data for Prospective Heart Medication; Shares Rise